Evnin Luke

Evnin Luke is listed in filings as Director at Werewolf Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 3, 2026, including sale activity. Recent filings connect the profile to Werewolf Therapeutics, Inc. (HOWL). The current snapshot covers public activity from Oct 29, 2025 to Jun 3, 2026. Reported amounts are shown as $12.5K to $37.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.